| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 妇科及计生用药(元) | 386,750,695.59 | 810,842,768.56 | 418,424,516.42 | 838,404,986.58 | 436,111,097.71 |
| 麻醉及肌松用药(元) | 125,449,484.32 | 252,489,533.52 | 129,573,898.43 | 175,412,173.56 | 89,639,378.40 |
| 皮质激素(元) | 1,184,877,005.64 | 2,512,337,217.27 | 1,233,732,668.28 | 2,441,347,916.24 | 1,199,293,204.40 |
| 其他(元) | 172,150,189.99 | 425,023,628.70 | 356,116,526.70 | 668,253,507.81 | 393,076,559.41 |
| 营业成本(元) | |||||
| 妇科及计生用药(元) | 130,471,222.21 | 304,284,488.41 | 155,209,244.44 | 297,747,461.05 | 160,144,834.78 |
| 麻醉及肌松用药(元) | 43,617,249.69 | 66,945,407.54 | 33,666,796.24 | 78,024,532.96 | 39,843,187.34 |
| 皮质激素(元) | 458,702,055.58 | 1,068,340,962.78 | 520,355,637.91 | 1,126,641,753.28 | 557,152,973.16 |
| 其他(元) | 55,823,241.67 | 261,271,700.51 | 256,166,164.50 | 440,710,581.68 | 266,237,603.15 |
| 毛利(元) | |||||
| 妇科及计生用药(元) | 256,279,473.38 | 506,558,280.15 | 263,215,271.98 | 540,657,525.53 | 275,966,262.93 |
| 麻醉及肌松用药(元) | 81,832,234.63 | 185,544,125.98 | 95,907,102.19 | 97,387,640.60 | 49,796,191.06 |
| 皮质激素(元) | 726,174,950.06 | 1,443,996,254.49 | 713,377,030.37 | 1,314,706,162.96 | 642,140,231.24 |
| 其他(元) | 116,326,948.32 | 163,751,928.19 | 99,950,362.20 | 227,542,926.13 | 126,838,956.26 |
| 毛利率(%) | |||||
| 妇科及计生用药(%) | 66.26 | 62.47 | 62.91 | 64.49 | 63.28 |
| 麻醉及肌松用药(%) | 65.23 | 73.49 | 74.02 | 55.52 | 55.55 |
| 皮质激素(%) | 61.29 | 57.48 | 57.82 | 53.85 | 53.54 |
| 其他(%) | 67.57 | 38.53 | 28.07 | 34.05 | 32.27 |
| 收入构成(%) | |||||
| 妇科及计生用药(%) | 20.69 | 20.27 | 19.57 | 20.33 | 20.59 |
| 麻醉及肌松用药(%) | 6.71 | 6.31 | 6.06 | 4.25 | 4.23 |
| 皮质激素(%) | 63.39 | 62.80 | 57.71 | 59.21 | 56.62 |
| 其他(%) | 9.21 | 10.62 | 16.66 | 16.21 | 18.56 |
| 毛利构成(%) | |||||
| 妇科及计生用药(%) | 21.71 | 22.03 | 22.45 | 24.80 | 25.21 |
| 麻醉及肌松用药(%) | 6.93 | 8.07 | 8.18 | 4.47 | 4.55 |
| 皮质激素(%) | 61.51 | 62.79 | 60.84 | 60.30 | 58.66 |
| 其他(%) | 9.85 | 7.12 | 8.52 | 10.44 | 11.59 |